Weekly Recap: Wholly owned drug sales shift and Rezilient3 6-month PFS
Jefferies raised its target to ¥14,000 as Otsuka Holdings Co., Ltd. (TSE:4578) shifts sales toward wholly owned drugs like Voyxact, with shares at ¥11,770, while Rezilient3’s Phase 3 data show zipalertinib plus chemo delivered a median 6—month PFS in first—line EGFR Exon20ins NSCLC.Previous Week Re…